Maxipime and Dermatitis exfoliative - a phase IV clinical study of FDA data

Summary:

Dermatitis exfoliative is reported as a side effect among people who take Maxipime (cefepime hydrochloride), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Vancomycin, and have Appetite - decreased.

The phase IV clinical study analyzes which people have Dermatitis exfoliative when taking Maxipime. It is created by eHealthMe based on reports of 4,272 people who have side effects when taking Maxipime from the FDA, and is updated regularly.

What is Maxipime?

Maxipime has active ingredients of cefepime hydrochloride. eHealthMe is studying from 4,279 Maxipime users. Check the latest studies of Maxipime.

What is Dermatitis exfoliative?

Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss) is found to be associated with 682 drugs and 945 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

4,272 people reported to have side effects when taking Maxipime.
Among them, 14 people (0.33%) have Dermatitis exfoliative.

Could Maxipime cause Dermatitis exfoliative?

Among these 14 people:

How long have people been on Maxipime when they have Dermatitis exfoliative? *

What is the gender of people who have Dermatitis exfoliative when taking Maxipime? *

female: 21.43 %
male: 78.57 %

What is the age of people who have Dermatitis exfoliative when taking Maxipime? *

What are other drugs people take besides Maxipime? *

What are other side effects people have besides Dermatitis exfoliative? *

Itching: 4 people, 28.57%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 21.43%
Constipation: 3 people, 21.43%
Oedema (fluid collection in tissue): 3 people, 21.43%
Hypernatraemia (an abnormally high plasma concentration of sodium ions): 2 people, 14.29%
Tongue Disorder (disease of tongue): 2 people, 14.29%
Ileus Paralytic (obstruction of the intestine due to paralysis of the intestinal muscles): 2 people, 14.29%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 14.29%
Hypokalemia (low potassium): 2 people, 14.29%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 2 people, 14.29%

What are the existing conditions these people have? *

T-Cell Lymphoma (a blood cell cancer): 2 people, 14.29%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 14.29%
Oedema (fluid collection in tissue): 2 people, 14.29%
Melaena (the passage of black, tarry stools): 2 people, 14.29%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 14.29%
Gastritis (inflammation of stomach): 2 people, 14.29%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 14.29%
Diarrhea: 2 people, 14.29%
Constipation: 2 people, 14.29%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Maxipime and have Dermatitis exfoliative?

- Check whether Dermatitis exfoliative is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Maxipime:

Maxipime (4,279 reports)

Browse all side effects of Maxipime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis exfoliative:

Dermatitis exfoliative (682 drugs)

Browse all the conditions that are associated with Dermatitis exfoliative:

Dermatitis exfoliative (945 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefepime hydrochloride (the active ingredients of Maxipime) and Maxipime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.